Pasithea Therapeutics Corp.
KTTA
$1.18
-$0.02-1.26%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.49M | -13.46M | -13.61M | -13.90M | -15.78M |
| Total Depreciation and Amortization | 667.30K | 648.00K | 648.60K | 649.20K | 649.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 321.30K | 430.50K | 561.30K | 851.60K | 262.60K |
| Change in Net Operating Assets | 248.20K | -109.70K | -260.80K | -1.52M | -522.50K |
| Cash from Operations | -12.26M | -12.49M | -12.66M | -13.92M | -15.39M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 54.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 594.40K |
| Cash from Investing | -- | -- | -- | -- | 648.90K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 7.51M | 7.51M | 1.65M | 300.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -432.80K | 4.22M | 4.34M | 4.52M | 4.54M |
| Cash from Financing | 7.07M | 11.73M | 5.99M | 4.52M | 4.54M |
| Foreign Exchange rate Adjustments | 46.40K | 6.60K | -1.90K | -2.50K | -27.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.14M | -750.50K | -6.67M | -9.41M | -10.22M |